{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:30:11Z","timestamp":1772166611983,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["2022-GSP-QN-13"],"award-info":[{"award-number":["2022-GSP-QN-13"]}],"id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["2022-GSP-GG-32"],"award-info":[{"award-number":["2022-GSP-GG-32"]}],"id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-024-02077-y","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T08:02:29Z","timestamp":1727769749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effects of standardized intravenous treprostinil in pulmonary arterial hypertension patients after total cavo-pulmonary connection procedure"],"prefix":"10.1186","volume":"29","author":[{"given":"Xiaofeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruihuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"issue":"4","key":"2077_CR1","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.21037\/cdt-20-431","volume":"11","author":"K Becker","year":"2021","unstructured":"Becker K, Uebing A, Hansen JH. Pulmonary vascular disease in Fontan circulation\u2014is there a rationale for pulmonary vasodilator therapies? Cardiovasc Diagn Ther. 2021;11(4):1111\u201321.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"5","key":"2077_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1017\/S1047951120004618","volume":"31","author":"M Al-Shawk","year":"2021","unstructured":"Al-Shawk M, Banjoko A, Axiaq A, Amin K, Harky A. Perioperative and long-term management of Fontan patients. Cardiol Young. 2021;31(5):775\u201385.","journal-title":"Cardiol Young"},{"issue":"1","key":"2077_CR3","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","volume":"53","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.","journal-title":"Eur Respir J"},{"issue":"6","key":"2077_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","volume":"42","author":"H Baumgartner","year":"2021","unstructured":"Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563\u2013645.","journal-title":"Eur Heart J"},{"key":"2077_CR5","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.110.981746","volume":"123","author":"DJ Goldberg","year":"2011","unstructured":"Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, et al. Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation. 2011;123:1185\u201393.","journal-title":"Circulation"},{"key":"2077_CR6","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.ijcard.2013.03.014","volume":"168","author":"J Rhodes","year":"2013","unstructured":"Rhodes J, Ubeda-Tikkanen A, Clair M, Fernandes SM, Graham DA, Milliren CE, et al. Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept. Int J Cardiol. 2013;168:2435\u201340.","journal-title":"Int J Cardiol"},{"key":"2077_CR7","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.113.008441","volume":"130","author":"A Hebert","year":"2014","unstructured":"Hebert A, Mikkelsen UR, Thilen U, Idorn L, Jensen AS, Nagy E, et al. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (treatment with endothelin receptor antagonist in fontan patients, a randomized, placebo-controlled, double-blind study measuring peak oxygen consumption) study. Circulation. 2014;130:2021\u201330.","journal-title":"Circulation"},{"issue":"1","key":"2077_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023035","volume":"11","author":"A Constantine","year":"2022","unstructured":"Constantine A, Dimopoulos K, Jenkins P, Tulloh RMR, Condliffe R, Jansen K, et al. Use of pulmonary arterial hypertension therapies in patients with a fontan circulation: current practice across the United Kingdom. J Am Heart Assoc. 2022;11(1): e023035.","journal-title":"J Am Heart Assoc"},{"key":"2077_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/petr.13106","volume":"22","author":"L Ablonczy","year":"2018","unstructured":"Ablonczy L, Tordas D, Kis E, Szatm\u00e1ri A. Use of subcutaneous Treprostinil in pediatric pulmonary arterial hypertension-Bridge-to-transplant or long-term treatment? Pediatr Transplant. 2018;22:2.","journal-title":"Pediatr Transplant."},{"issue":"14","key":"2077_CR10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.21037\/atm-21-3188","volume":"9","author":"X Chen","year":"2021","unstructured":"Chen X, Cai XM, Zhang MJ, Xu JH, Li H, Xu ZM. Pharmacokinetics of Treprostinil in children with functional single-ventricle pulmonary arterial hypertension: a randomized controlled trial. Ann Transl Med. 2021;9(14):1163.","journal-title":"Ann Transl Med"},{"issue":"22","key":"2077_CR11","first-page":"00191","volume":"S1043\u20130679","author":"RT Sullivan","year":"2022","unstructured":"Sullivan RT, Handler SS, Feinstein JA, Ogawa M, Liu E, Ma M, et al. Subcutaneous treprostinil improves surgical candidacy for next stage palliation in single ventricle patients with high-risk hemodynamics. Semin Thorac Cardiovasc Surg. 2022;S1043\u20130679(22):00191\u20135.","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"8","key":"2077_CR12","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00246-020-02424-w","volume":"41","author":"I Jeremiasen","year":"2020","unstructured":"Jeremiasen I, Tran-Lundmark K, Idris N, Tran PK, Moledina S. Pulmonary vasodilator therapy in children with single ventricle physiology: effects on saturation and pulmonary arterial pressure. Pediatr Cardiol. 2020;41(8):1651\u20139.","journal-title":"Pediatr Cardiol"},{"issue":"14","key":"2077_CR13","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.2022.4402","volume":"327","author":"NF Ruopp","year":"2022","unstructured":"Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA. 2022;327(14):1379\u201391.","journal-title":"JAMA"},{"issue":"1","key":"2077_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.kint.2016.11.029","volume":"92","author":"E Siddall","year":"2017","unstructured":"Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management. Kidney Int. 2017;92(1):37\u201346.","journal-title":"Kidney Int"},{"issue":"3","key":"2077_CR15","first-page":"507","volume":"4","author":"N Skoro-Sajer","year":"2008","unstructured":"Skoro-Sajer N, Lang I, Naeije R. Treprostinil for pulmonary hypertension. Vasc Health Risk Manag. 2008;4(3):507\u201313.","journal-title":"Vasc Health Risk Manag"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02077-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-02077-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02077-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T08:09:30Z","timestamp":1727770170000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-02077-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2077"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-02077-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4169877\/v1","asserted-by":"object"}]},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"479"}}